TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.5μM, Day 4 [Pac0.5muMR2]
TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.5μM, Day 4 [Pac0.5muMR1]
TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.05μM, Day 4 [Pac0.05muMR2]
TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.05μM, Day 4 [Pac0.05muMR1]
TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.005μM, Day 4 [Pac0.005muMR2]
TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.005μM, Day 4 [Pac0.005muMR1]
TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.0005μM, Day 4 [Pac0.0005muMR2]
TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.0005μM, Day 4 [Pac0.0005muMR1]
TNBC cells from MDA-MB-231 cell line, no treatment, Day 4 [C2R2]
TNBC cells from MDA-MB-231 cell line, no treatment, Day 4 [C2R1]
TNBC cells from MDA-MB-231 cell line, no treatment, Day 2 [C1R2]
TNBC cells from MDA-MB-231 cell line, no treatment, Day 2 [C1R1]